McCormick & Company, Incorporated Voting CS MKC.V

In its 135-plus-year history, McCormick has become the leading global manufacturer of spices, herbs, extracts, seasonings, and other flavorings. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and Cholula. This mix will be complemented by the pending addition of Unilever's food brands, primarily Knorr cooking aids and Hellmann's mayonnaise. After the deal close, the combined business is slated to generate 70% of sales from consumers and 30% from restaurants and other packaged food and beverage manufacturers. Around 40% of sales are slated to come from faster-growing emerging markets, with Europe (23%) and North America (36%) accounting for the remainder.

Con 21 acciones de MKC.V (USD 982,17) habrías recibido USD 30,24 en dividendos en los últimos 12 meses.

MKC.V hizo una división de acciones (split) de 2:1 el 1 de diciembre de 2020: cada acción se convirtió en 2. Cambió la cantidad de acciones y su precio, pero no el valor total de la inversión.

• The Motley Fool 4 oct

  2 High-Yield Stocks to Buy in October Without Any Hesitation

  The author recommends two high-yield dividend stocks for October: Medtronic (MDT), which has completed a business overhaul and is approaching Dividend King status with a 3.3% yield, and McCormick (MKC), a consumer staples company with 39 years of dividend increases and a 4.2% yield that is acquiring Unilever's food business to roughly double its sales.

  

• The Motley Fool 2 oct

  Cooper Companies Director Kurzius Buys $549,300 in Shares. Is the Eye Care Stock About to Rally?

  Lawrence Erik Kurzius, a Director at Cooper Companies, purchased 10,000 shares worth $549,300 at $54.93 per share on September 16, 2026, increasing his total holdings to 31,099 shares. The insider buy signals confidence in the company's recovery prospects following a 16% stock decline over the past year. The article notes that insider purchases typically predict higher share prices within 30 days and suggest management believes in the company's long-term growth, particularly after deciding to retain its surgical unit rather than divest it.

  

• Zacks Investment Research 1 oct

  MKC Q3 Earnings Beat Estimates on Margin Gains and Mexico Growth

  McCormick & Company delivered solid Q3 fiscal 2026 results with net sales rising 17.4% to $2,024.8 million, driven by the McCormick de Mexico acquisition and 1.9% organic growth. Adjusted earnings of 86 cents per share beat consensus estimates, while adjusted gross margin expanded 180 basis points to 39.3%. The company reaffirmed its fiscal 2026 outlook but expects higher commodity and freight costs in Q4, with a packaging constraint potentially reducing full-year organic growth by 30 basis points.

  

• Zacks Investment Research 1 oct

  McCormick (MKC) Surpasses Q3 Earnings and Revenue Estimates

  McCormick reported Q3 earnings of $0.86 per share, beating consensus estimates of $0.75, with revenues of $2.02 billion exceeding expectations. However, the stock carries a Zacks Rank #4 (Sell) rating due to unfavorable estimate revisions and has underperformed the market by 31.9% year-to-date. Mondelez is expected to report Q3 earnings of $0.71 per share with revenues of $9.97 billion.

  

• Zacks Investment Research 29 sept

  McCormick Readies for Q3 Earnings: What to Expect From MKC Stock?

  McCormick & Company is expected to report Q3 2026 revenues rising 14.7% to ~$2 billion, but earnings may fall 11.8% to 75 cents per share. Growth drivers include the Flavor Solutions segment, pricing actions, and CCI productivity savings, while headwinds include consumer price sensitivity, competitive pressures, and inflationary expenses. The company carries a Zacks Rank #4 (Sell) with a negative Earnings ESP of -1.97%, suggesting limited likelihood of an earnings beat.